Company intelligence / Profile preview

Guangzhou Yuekang Biopharmaceutical Co., Ltd.

Guangzhou, Guangdong, Chinaintrepidalliance.org ↗

Ownership: Private
Development stage: Phase 3

Overview

Guangzhou Yuekang Biology Pharmacy Co. Ltd. has several approved and late-stage products in China, including human placental tissue hydrolysate for surgical adhesion and female genital diseases, as well as traditional Chinese medicine formulations targeting coughs and respiratory symptoms. Some programs are at the NDA/BLA stage but not yet fully commercialized.

Therapeutic areas: OtherPulmonologyWomen's Health
Modalities: Small molecule drugsBiological drugsHerbal/traditional Chinese medicines
Industry: Biotech

Drug pipeline

1 asset

Shufeng Wenfei Zhike

Unknown

Partnerships

No major international pharmaceutical partnerships publicly disclosed; possible collaborations within China’s TCM/pharma sector.

Beyond the preview

Go deeper on Guangzhou Yuekang Biopharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Yuekang Biopharmaceutical Co., Ltd..

Explore the full profile